How much is Septerna worth in 2026?

Septerna has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Septerna raised?

Septerna has raised N/A in total funding across 1 funding rounds.

Septerna

Drug Discovery

Septerna valuation and funding history | Last updated: May 24, 2024 | 1 funding rounds

Current Valuation

N/A

As of May 24, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series B)

$150.0M

Last Funding

May 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 24, 2024	Early Stage VC (Series B)	$150.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Septerna is currently valued at N/A as of May 24, 2024.

Track Septerna Valuation Updates

Get notified when Septerna raises new funding or valuation changes

Explore More Data

Detailed analysis for Septerna

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Septerna's valuation history, funding rounds, and growth metrics.

No credit card required

What is Septerna Worth in 2026?

Septerna is a leading private company in the Drug Discovery sector. Track Septerna's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Septerna Valuation is Determined

Private company valuations like Septerna's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.